- Home
- EAD vs SRPT Comparison
EAD vs SRPT Comparison
Compare EAD & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EAD | SRPT |
|---|---|---|
| Founded | 2003 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 394.7M | 2.4B |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | EAD | SRPT |
|---|---|---|
| Price | $6.65 | $17.14 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 28 |
| Target Price | N/A | ★ $25.76 |
| AVG Volume (30 Days) | 154.4K | ★ 2.0M |
| Earning Date | 01-01-0001 | 06-01-2026 |
| Dividend Yield | ★ 8.91% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,198,237,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 15.58 |
| 52 Week Low | $5.89 | $10.42 |
| 52 Week High | $7.18 | $80.26 |
Technical Indicators
Market Signals| Indicator | EAD | SRPT |
|---|---|---|
| Relative Strength Index (RSI) | 38.02 | 45.93 |
| Support Level | N/A | $17.05 |
| Resistance Level | $6.89 | $19.55 |
| Average True Range (ATR) | 0.07 | 0.83 |
| MACD | -0.01 | 0.13 |
| Stochastic Oscillator | 34.38 | 65.24 |
Price Performance
Historical ComparisonAbout EAD Allspring Income Opportunities Fund
Allspring Income Opportunities Fund is a diversified closed-end management investment company. Its products and services are mutual funds, closed-end funds, managed accounts services, and variable trust funds. The fund's objective is a high level of current income and capital appreciation. Its portfolio of investments is Commercial services, healthcare services, Food, Pharmaceuticals, Energy, Oil & gas, Pipelines, Diversified financial services, and Others.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.